Julius Popp

Medicine · Health Sciences

57h-index13.4kcitations277works4.62yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Alzheimer's disease research and treatments(117), Dementia and Cognitive Impairment Research(98), Bioinformatics and Genomic Networks(27), Genetic Associations and Epidemiology(23), Metabolomics and Mass Spectrometry Studies(22)

Publications264 total

Omics-AD—A multimodal biomarker study on cognitive decline and neuropsychiatric symptoms: Design and cohort characteristics
Journal of Alzheimer s Disease·2025Open Access
Cerebrospinal fluid proteome alterations related to depressive symptoms in cognitive decline and Alzheimer's disease
Alzheimer s & Dementia·2025Open Access
Cerebrospinal fluid proteome associations with neuropsychiatric symptoms in Alzheimer's disease
Alzheimer s & Dementia·2025Open Access
Associations of lifestyle factors with amyloid pathology in persons without dementia
Journal of Alzheimer s Disease·2025Open Access
The association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohorts
Alzheimer s & Dementia·2025Open Access
Cerebrospinal fluid proteomic associations of <i>APOE</i> genotypes reveal distinct protective and risk mechanisms for Alzheimer's disease
Alzheimer s & Dementia·2025· 1 citedOpen Access
Polygenic Hazard Score for Predicting Age-associated Risk of Alzheimer’s Disease in European Populations: Development and Validation
2025· 1 citedOpen Access
Machine learning in Alzheimer’s disease genetics
Nature Communications·2025· 5 citedOpen Access
<i>APOE</i> stratified genome-wide association studies provide novel insights into the genetic etiology of Alzheimers’s disease
2025· 1 citedOpen Access
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer Disease: Intersocietal Recommendations for Their Appropriate Use in Switzerland
Neurodegenerative Diseases·2025· 3 citedOpen Access
[The Swiss Memory Clinics recommendations for the diagnosis of dementia - an update].
PubMed·2025
Conference report: Trends, new technologies and implications for dementia diagnostics, treatment and care in Switzerland
Swiss Medical Weekly·2025Open Access
Synaptic protein CSF levels relate to memory scores in individuals without dementia
Alzheimer s Research & Therapy·2025· 4 citedOpen Access
Cortisol and 10‐Year Cognitive Decline in Older People From the General Population
European Journal of Neurology·2025Open Access
Depressive Symptoms and Amyloid Pathology
JAMA Psychiatry·2025· 17 citedOpen Access
Cerebrospinal fluid proteomic profiling of cognitively unimpaired individuals with suspected non-Alzheimer's disease pathophysiology
Brain Communications·2025· 2 citedOpen Access
[Alzheimer's disease - system prepardeness in the context of new developments].
PubMed·2024· 1 cited
Plasma NfL, ptau181 and GFAP as potential biomarkers for neuropsychiatric symptoms and related long‐term outcomes in a memory clinic cohort
Alzheimer s & Dementia·2024Open Access
Extremely rare CNVs contributing to Alzheimer disease risk: a case-control association analysis of exome sequencing data from 22,319 individuals
2024Open Access
Neuropsychiatric symptoms in cognitive decline and Alzheimer’s disease: biomarker discovery using plasma proteomics
Journal of Neurology Neurosurgery & Psychiatry·2024· 14 citedOpen Access
page 1 of 14Next →

Frequent Co-authors

Frank Jessen(19), Philip Scheltens(16), Kaj Blennow(15), Pieter Jelle Visser(13), Sebastiaan Engelborghs(13), Alberto Lleó(13), José Luís Molinuevo(13), Magda Tsolaki(12), Rik Vandenberghe(12), Henrik Zetterberg(12), Giovanni B. Frisoni(11), Johannes Kornhuber(11), Lars Bertram(11), Wolfgang Maier(10), Oliver Peters(10), Heike Kölsch(10), Pablo Martínez‐Lage(10), Simon Lovestone(10), Johannes Streffer(10), Isabelle Bos(10)